Atrial fibrillation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) age =45 years, =85 years; 2) any gender; 3) meet non-valvular AF anticoagulation criteria: CHA2DS2-VASC score for men =1, and for women=2 ; 4) no digestive system cancer or other systemic malignancy; 5) no history of digestive tract operation ; 6) no use of antibiotics or probiotics in the last 3 months; 7) no use of proton pump inhibitors(PPIs), or H2 receptor antagonists in the last 3 months;(8) No concomitant aspirin; (9) No history of psychiatric or genetic disorders; (10) Voluntarily accept and comply with the study proposal,tolerate relevant tests, and can complete the questionnaire independently under the guidance of the investigator, and accept the review and clinical follow-up on time.
Exclusion criteria
Exclusion criteria: 1) age 85 years; 2) valvular AF; 3) patients who were on warfarin and are changing to NOAC; 4) contraindication to anticoagulation; 5) any digestive system cancer or other systemic malignancy; 6) history of digestive tract operation; 7) use of antibiotics or probiotics in the last 3 months; 8) use of proton pump inhibitors or H2 receptor antagonists in the last 3 months; 9) need for concomitant aspirin; 10) history of psychiatric or genetic disorders; 11) patients who do not wish to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Flora; | — |
Countries
China
Contacts
Suining Central Hospital